N M J Zwifelhofer1, R S Bercovitz2,3, L A Weik4, A Moroi1, S LaRose1, P J Newman1,5, D K Newman1,6,7. 1. Blood Research Institute, BloodCenter of Wisconsin - part of Versiti, Milwaukee, WI, USA. 2. Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. 3. Department of Pediatrics, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 4. Children's Hospital of Wisconsin, Milwaukee, WI, USA. 5. Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA. 6. Department of Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA. 7. Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Abstract
Essentials How thrombocytopenia relates to bleeding in 22q11 deletion syndrome (22q11DS) is not clear. Bleeding severity, platelet count and volume, and GPIBB were examined in patients with 22q11DS. Macrothrombocytopenia and bleeding typified imperfectly overlapping subsets of 22q11DS patients. GPIBB hemizygosity does not cause macrothrombocytopenia or bleeding in patients with 22q11DS. SUMMARY: Background and objectives Macrothrombocytopenia and bleeding are frequently associated with 22q11 deletion syndrome (22q11DS). GPIBB, which encodes the glycoprotein (GP) Ibβ subunit of GPIb-IX-V, is commonly deleted in patients with 22q11DS. Absence of functional GPIb-IX-V causes Bernard-Soulier syndrome, which is a severe bleeding disorder characterized by macrothrombocytopenia. Patients with 22q11DS are often obligate hemizygotes for GPIBB, and those with only a pathogenically disrupted copy of GPIBB present with Bernard-Soulier syndrome. The objective of this study was to determine how GPIBB hemizygosity and sequence variation relate to macrothrombocytopenia and bleeding in patients with 22q11DS who do not have Bernard-Soulier syndrome. Patients/methods We thoroughly characterized bleeding severity, mean platelet volume, platelet count and GPIBB copy number and sequence in patients with 22q11DS. Results and conclusions Macrothrombocytopenia and mild bleeding were observed in incompletely overlapping subsets of patients, and GPIBB copy number and sequence variation did not correlate with either macrothrombocytopenia or bleeding in patients with 22q11DS. These findings indicate that GPIBB hemizygosity does not result in either macrothrombocytopenia or bleeding in these patients. Alternative genetic causes of macrothrombocytopenia, potential causes of acquired thrombocytopenia and bleeding and ways in which platelet size, platelet count and GPIBB sequence information can be used to aid in the diagnosis and management of patients with 22q11DS are discussed.
Essentials How thrombocytopenia relates to bleeding in 22q11 deletion syndrome (22q11DS) is not clear. Bleeding severity, platelet count and volume, and GPIBB were examined in patients with 22q11DS. Macrothrombocytopenia and bleeding typified imperfectly overlapping subsets of 22q11DS patients. GPIBB hemizygosity does not cause macrothrombocytopenia or bleeding in patients with 22q11DS. SUMMARY: Background and objectives Macrothrombocytopenia and bleeding are frequently associated with 22q11 deletion syndrome (22q11DS). GPIBB, which encodes the glycoprotein (GP) Ibβ subunit of GPIb-IX-V, is commonly deleted in patients with 22q11DS. Absence of functional GPIb-IX-V causes Bernard-Soulier syndrome, which is a severe bleeding disorder characterized by macrothrombocytopenia. Patients with 22q11DS are often obligate hemizygotes for GPIBB, and those with only a pathogenically disrupted copy of GPIBB present with Bernard-Soulier syndrome. The objective of this study was to determine how GPIBB hemizygosity and sequence variation relate to macrothrombocytopenia and bleeding in patients with 22q11DS who do not have Bernard-Soulier syndrome. Patients/methods We thoroughly characterized bleeding severity, mean platelet volume, platelet count and GPIBB copy number and sequence in patients with 22q11DS. Results and conclusions Macrothrombocytopenia and mild bleeding were observed in incompletely overlapping subsets of patients, and GPIBB copy number and sequence variation did not correlate with either macrothrombocytopenia or bleeding in patients with 22q11DS. These findings indicate that GPIBB hemizygosity does not result in either macrothrombocytopenia or bleeding in these patients. Alternative genetic causes of macrothrombocytopenia, potential causes of acquired thrombocytopenia and bleeding and ways in which platelet size, platelet count and GPIBB sequence information can be used to aid in the diagnosis and management of patients with 22q11DS are discussed.
Authors: Michele P Lambert; Abinaya Arulselvan; Amanda Schott; Stephen J Markham; Terrance B Crowley; Elaine H Zackai; Donna M McDonald-McGinn Journal: Am J Med Genet A Date: 2017-09-22 Impact factor: 2.802
Authors: Ingrid Bartsch; Kirstin Sandrock; Francois Lanza; Paquita Nurden; Ina Hainmann; Anna Pavlova; Andreas Greinacher; Uta Tacke; Michael Barth; Anja Busse; Johannes Oldenburg; Martin Bommer; Brigitte Strahm; Andrea Superti-Furga; Barbara Zieger Journal: Thromb Haemost Date: 2011-07-28 Impact factor: 5.249
Authors: B Zieger; A Jenny; D A Tsakiris; I Bartsch; K Sandrock; C Schubart; S Schäfer; An Busse; Walter A Wuillemin Journal: Hamostaseologie Date: 2009-05 Impact factor: 1.778
Authors: Kazunobu Kato; Constantino Martinez; Susan Russell; Paquita Nurden; Alan Nurden; Steven Fiering; Jerry Ware Journal: Blood Date: 2004-06-22 Impact factor: 22.113
Authors: Michelle K Brenner; Shanelle Clarke; Donna K Mahnke; Pippa Simpson; Rachel S Bercovitz; Aoy Tomita-Mitchell; Michael E Mitchell; Debra K Newman Journal: Pediatr Res Date: 2015-10-22 Impact factor: 3.756